Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 52.65% | 387.88% | -32.97% | -22.93% | -34.14% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Amortization of Deferred Charges | -100.00% | -32.81% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -91.09% | -1,169.29% | 0.07% | 14.24% | -2.52% |
| Change in Net Operating Assets | -615.85% | -209.08% | 603.70% | -104.95% | 184.16% |
| Cash from Operations | 13.76% | 9.44% | -1.69% | -5,181.02% | -45.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.76% | 11.05% | -124.89% | -5,181.02% | -45.20% |